Normal subjects |
35(11%) |
volume quantification of LV and RV anatomical and functional assessment of MV and TV |
|
Ischemic Heart Disease |
35(11%) |
volume quantification of LV and RV |
|
Cardiomyopathies |
44(13.7%) |
volume quantification of LV and RV |
|
Pulmonary hypertension |
13(4.3%) |
volume quantification of RV anatomical and functional assessment of TV |
|
Rheumatic Heart Disease |
50(16.6%) |
anatomical and functional assessment of all valves |
|
Prosthetic valves and rings |
30(10%) |
anatomical and functional assessment of all valves |
|
Congenital heart disease |
|
|
• MVP |
5(1.7%) |
Define the prolapsed scallop and assess mitral regurgitation |
• ASD |
18(6%) |
|
• VSD |
6(2%) |
Measure number, size& rims. |
• PFO |
3(1%) |
|
• Malformed AV |
25(8%) |
Define cusps (number & morphology). Measure valve area |
• PS |
5(1.7%) |
|
|
Intracardiac masses and thrombi |
52(17.3%) |
Anatomical delineation and volume calculation |